Malaysia's approved Indian-linked manufacturing portfolio will cross US$3.5 billion by mid-2027, but the additional growth will come disproportionately from transport and metals projects rather than pharmaceuticals or renewables.
As of June 2026, Malaysia had approved 293 such projects worth US$2.95 billion, with 180 projects worth US$1.48 billion already implemented, spread across textiles, pharmaceuticals, chemicals, petrochemicals, metal products, transport and renewable energy. Green and health sectors are widely assumed to dominate this pipeline, but infrastructure firms like IJM and Eversendai already sit alongside renewables player Gentari India in the mix.
As of June 2026, Malaysia had approved 293 such projects worth US$2.95 billion, with 180 projects worth US$1.48 billion already implemented, spread across textiles, pharmaceuticals, chemicals, petrochemicals, metal products, transport and renewable energy. Green and health sectors are widely assumed to dominate this pipeline, but infrastructure firms like IJM and Eversendai already sit alongside renewables player Gentari India in the mix.